HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism.

AuthorsMaria Lucia Narducci, Carlo Patrono
JournalEuropean heart journal (Eur Heart J) Vol. 42 Issue 40 Pg. 4109-4110 (10 21 2021) ISSN: 1522-9645 [Electronic] England
PMID34519340 (Publication Type: Journal Article, Comment)
Chemical References
  • Anticoagulants
  • Factor XI
Topics
  • Anticoagulants (therapeutic use)
  • Blood Coagulation Tests
  • Factor XI
  • Humans
  • Venous Thromboembolism (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: